| scholarly article | Q13442814 |
| P50 | author | Molly Stevens | Q15896847 |
| Alexander N. Zelikin | Q39935869 | ||
| Rona Chandrawati | Q42290270 | ||
| Marja Ter Meer | Q59564782 | ||
| Ross Dillion | Q88145496 | ||
| P2093 | author name string | Leo J Schultze Kool | |
| Ulf Simonsen | |||
| Anna K Winther | |||
| Betina Fejerskov | |||
| Jeremy E Schaffer | |||
| Najah B S Jensen | |||
| P2860 | cites work | Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 |
| Nitric oxide and virus infection | Q27485884 | ||
| Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films | Q27487098 | ||
| Substrate mediated enzyme prodrug therapy | Q28485159 | ||
| Nitric oxide and macrophage function | Q29615327 | ||
| Molecular basis for the explanation of the exponential growth of polyelectrolyte multilayers | Q30531638 | ||
| Interaction and adhesion properties of polyelectrolyte multilayers | Q33220302 | ||
| Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma | Q33589704 | ||
| Generic nitric oxide (NO) generating surface by immobilizing organoselenium species via layer-by-layer assembly | Q33666779 | ||
| Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications | Q33951477 | ||
| Nitric oxide release: part I. Macromolecular scaffolds | Q35926045 | ||
| Nitric oxide release: part II. Therapeutic applications | Q35926097 | ||
| Release of plasmid DNA from intravascular stents coated with ultrathin multilayered polyelectrolyte films | Q36848895 | ||
| Influence of chirality on catalytic generation of nitric oxide and platelet behavior on selenocystine immobilized TiO2 films | Q37100376 | ||
| Drug releasing polymer thin films: new era of surface-mediated drug delivery | Q37737717 | ||
| Nitric oxide: a guardian for vascular grafts? | Q37887771 | ||
| Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents | Q38861841 | ||
| Biocatalytic polymer thin films: optimization of the multilayered architecture towards in situ synthesis of anti-proliferative drugs | Q39017881 | ||
| Intracellular nitric oxide delivery from stable NO-polymeric nanoparticle carriers. | Q39243266 | ||
| Substrate mediated enzyme prodrug therapy. | Q39273662 | ||
| Prodrugs in medicinal chemistry and enzyme prodrug therapies | Q39414016 | ||
| Nitric oxide: a physiologic messenger molecule | Q40394921 | ||
| Nitric oxide signaling in the central nervous system | Q40401511 | ||
| Nitric oxide: mediator, murderer, and medicine | Q40622626 | ||
| Rational design of cytophilic and cytophobic polyelectrolyte multilayer thin films | Q40678375 | ||
| Role of nitric oxide in genotoxicity: implication for carcinogenesis | Q41739519 | ||
| Antiproliferative effect in human prostatic smooth muscle cells by nitric oxide donor | Q42451954 | ||
| Multilayer buildup and biofouling characteristics of PSS-b-PEG containing films. | Q43141841 | ||
| Nanocoatings onto arteries via layer-by-layer deposition: toward the in vivo repair of damaged blood vessels | Q44481738 | ||
| Protein adsorption modalities on polyelectrolyte multilayers | Q44887792 | ||
| A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 t | Q47201041 | ||
| Controlling the surface-mediated release of DNA using 'mixed multilayers'. | Q51076259 | ||
| Decellularized umbilical artery treated with thin polyelectrolyte multilayer films: potential use in vascular engineering. | Q51167991 | ||
| Biocatalytic polymer coatings: on-demand drug synthesis and localized therapeutic effect under dynamic cell culture conditions. | Q51762759 | ||
| Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. | Q52241033 | ||
| Enzyme-functionalized vascular grafts catalyze in-situ release of nitric oxide from exogenous NO prodrug. | Q52941257 | ||
| In vitro simultaneous measurements of relaxation and nitric oxide concentration in rat superior mesenteric artery. | Q54103479 | ||
| The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium | Q69813452 | ||
| Catalytic generation of nitric oxide from S-nitrosothiols using immobilized organoselenium species | Q80227934 | ||
| Adsorption of IgG on/in a PAH/PSS multilayer film: Layer structure and cell response | Q82340519 | ||
| Immobilization of selenocystamine on TiO2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents | Q82532853 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 10741-10751 | |
| P577 | publication date | 2018-03-23 | |
| P1433 | published in | ACS Applied Materials and Interfaces | Q2819060 |
| P1476 | title | Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide | |
| P478 | volume | 10 |
Search more.